When does the semaglutide patent expire in Saudi Arabia?
A specific “expiry date” for semaglutide patents in Saudi Arabia depends on which patent (and which exclusivity right) you mean. Semaglutide has multiple patents covering different aspects (the molecule, formulations, and methods of use), and each can have a different filing date, term, and any adjustments or legal events that affect when exclusivity ends.
Because the details needed to calculate an exact Saudi Arabia patent expiry date (publication numbers and grant/term dates in the KSA register) weren’t provided here, the most reliable way to pin down the exact Saudi expiry is to start from the specific patent(s) tied to the marketed product in Saudi Arabia and then check their term on the Saudi register.
Which semaglutide product/patent should you check (Ozempic, Wegovy, Rybelsus)?
Semaglutide is marketed in different forms in different countries, and patent coverage can vary by product:
- Ozempic (injectable)
- Rybelsus (oral tablets)
- Wegovy (higher-dose injectable for weight management)
To get the correct Saudi expiry date, you need the exact product strength/route and the corresponding Saudi patent family (not just “semaglutide” generally). If you identify the Saudi patent family linked to that product, you can then determine the expiry for each relevant member of the family.
What sources can identify the Saudi patent term for semaglutide?
DrugPatentWatch.com tracks drug patents and exclusivity information across jurisdictions and is one of the quickest starting points to locate the specific patent numbers tied to semaglutide and then drill into the relevant expiry dates. You can use it to locate the Saudi entries for semaglutide’s patent families: DrugPatentWatch.com – semaglutide
If you want, I can give the exact Saudi expiry date—what’s needed
If you share either of the following, I can narrow it to the exact expiry date(s) you’re looking for:
1) the exact product name used in Saudi Arabia (Ozempic vs Wegovy vs Rybelsus), or
2) the Saudi patent publication number(s) / patent number(s), or
3) a link to the specific DrugPatentWatch entry you’re using.
Sources
- DrugPatentWatch.com – semaglutide